Provectus Biopharmaceuticals, Inc.

PVCT · OTC
Analyze with AI
$0.06−$0.0039 (−6.17%)
At close:Dec 15, 2025, 8:54 PM UTC
$0.06+$0.00 (+0.07%)
After hours:Dec 15, 2025, 9:00 PM UTC
P/E TTM-3.76
P/B TTM-4.09
P/S TTM71.91
Dividend Yield0%
EPS-$0.01
Beta0.668
Valuation
PEG Ratio0.81
FCF Yield-13.37%
EV / EBITDA-5.49
Quality
ROIC201.38%
Gross Margin-8.89%
Cash Conv. Ratio0.50
Growth
Revenue 3Y CAGR-14.55%
FCF Growth-27.69%
Safety
Net Debt / EBITDA-0.67
Interest Coverage-40.47
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-307,942.87

Provectus Biopharmaceuticals, Inc. (PVCT) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Provectus Biopharmaceuticals, Inc. (PVCT) stock price today?

As of Dec 15, 2025, 8:54 PM UTC, Provectus Biopharmaceuticals, Inc. (PVCT) stock is trading at $0.06. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date PVCT stock quotes for informed trading decisions.

What is Provectus Biopharmaceuticals, Inc.'s market capitalization?

Provectus Biopharmaceuticals, Inc. (PVCT) has a market capitalization of approximately $25.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Provectus Biopharmaceuticals, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the PVCT stock price changes.

What is the 52-week range for Provectus Biopharmaceuticals, Inc. stock?

Provectus Biopharmaceuticals, Inc. (PVCT) stock has traded in a 52-week range of $0.05 — $0.135. The 52-week range shows the highest and lowest prices at which PVCT traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Provectus Biopharmaceuticals, Inc. stock price to this range provides context for recent price action.

How much trading volume does Provectus Biopharmaceuticals, Inc. stock have?

Provectus Biopharmaceuticals, Inc. (PVCT) stock recently traded approximately 228.4K shares. Trading volume indicates market liquidity and investor interest in PVCT. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Provectus Biopharmaceuticals, Inc. stock.

Does Provectus Biopharmaceuticals, Inc. pay dividends to shareholders?

Yes, Provectus Biopharmaceuticals, Inc. (PVCT) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Provectus Biopharmaceuticals, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Provectus Biopharmaceuticals, Inc.'s intraday price range?

Today, Provectus Biopharmaceuticals, Inc. (PVCT) stock has traded in a range of $0.052 — $0.0623. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring PVCT's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Provectus Biopharmaceuticals, Inc. stock data?

AlphaPilot sources real-time PVCT stock quotes, fundamental financial data, and historical price charts for Provectus Biopharmaceuticals, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Provectus Biopharmaceuticals, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of PVCT stock performance.